TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
Clinical trial NCT06802081 · RECRUITING
Trial details
- NCT number
- NCT06802081
- Sponsor
- The Cleveland Clinic
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-08
- Primary completion
- 2026-12-31
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.